Article Details

BTK Inhibitor Treatment Strategies in Chronic Lymphocytic Leukemia - Cancer Network

Retrieved on: 2023-11-15 15:08:25

Tags for this article:

Click the tags to see associated articles and topics

BTK Inhibitor Treatment Strategies in Chronic Lymphocytic Leukemia - Cancer Network. View article details on hiswai:

Excerpt

An atrial fibrillation and flutter rate of 3.7% with zanubrutinib is quite comparable with approximately 4% in acalabrutinib when we think about all- ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up